Merck to spin off women’s health, legacy brands and biosimilars into new companyMerck's yet to be named new company expects to establish a leading position in biosimilars along with its partner, Samsung Bioepis. HDA taps AAM's Chip Davis as CEOChester "Chip" Davis' is leaving AAM, to serve as HDA president and CEO; Jeffrey Francer, AAM's senior vice president and general counsel, will serve as interim AAM CEO. Dr. Reddy’s debuts generic Syprine Dr. Reddy's generic Syprine offers an alternative that can be stored at room temperature throughout its 24-month shelf life. Lupin gets FDA blessing for generic Arava Leflunomide tablets had a market value of roughly $44 million, according to December 2019 IQVIA data. Towa closes acquisition of Esteve's generics division Breckenridge is among the companies included in the acquisition. Augia Pharma gets FDA nod for generic Rheumatrex Methotrexate tablets have a market value of roughly $98 million for the 12 months ended December 2019, according to IQVIA. Global sales of branded generics are expected to grow by 8% Antihypertensives are expected to be the best-selling global branded generics category. FDA clear 2 generics from Alembic Clobetasol propionate cream and azithromycin tablets had a market value of $57 million, and $129 million respectively. Upsher-Smith launches generic Kapvay Clonidine hydrochloride ER tablets had a market value of approximately $30 million for the 12 months ended November 2019, according to IQVIA. Par launches authorized generic Carafate Sucralfate oral suspension had a market value of roughly $285 million for the 12 months ended Nov. 30, 2019, according to IQVIA. First Previous 149 150 151 152 153 Next Last